Indonesian (IDX) Pharma Industry Analysis

UpdatedMar 13, 2026

DataAggregated Company Financials

Companies8

7D-8.2%
3M-3.5%
1Y20.5%
YTDn/a

Over the last 7 days, the Pharma industry has dropped 3.9%, driven by pullbacks from every company within the industry. Over the past 12 months, the industry was up 23%. Looking forward, earnings are forecast to grow by 9.8% annually.

Industry Valuation and Performance

Has the Indonesian Pharma Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Fri, 13 Mar 2026	Rp91.8t	Rp74.5t	Rp4.6t	10.4x	19.9x	1.2x
Sun, 08 Feb 2026	Rp112.6t	Rp74.5t	Rp4.6t	10.9x	24.4x	1.5x
Tue, 06 Jan 2026	Rp99.1t	Rp74.5t	Rp4.6t	10.7x	21.5x	1.3x
Thu, 04 Dec 2025	Rp96.4t	Rp74.3t	Rp4.6t	10.7x	21x	1.3x
Sat, 01 Nov 2025	Rp109.1t	Rp74.2t	Rp4.3t	10.7x	25.6x	1.5x
Mon, 29 Sep 2025	Rp85.9t	Rp73.2t	Rp4.2t	11.5x	20.7x	1.2x
Wed, 27 Aug 2025	Rp91.3t	Rp73.6t	Rp4.0t	11.9x	22.7x	1.2x
Fri, 25 Jul 2025	Rp99.2t	Rp73.2t	Rp4.1t	11.3x	24.2x	1.4x
Sun, 22 Jun 2025	Rp98.1t	Rp72.8t	Rp3.3t	11.4x	29.8x	1.3x
Tue, 20 May 2025	Rp98.5t	Rp86.9t	Rp3.6t	11.3x	27.3x	1.1x
Thu, 17 Apr 2025	Rp87.4t	Rp86.5t	Rp3.7t	10.5x	23.5x	1x
Sat, 15 Mar 2025	Rp75.1t	Rp70.6t	Rp3.1t	11.9x	23.9x	1.1x
Mon, 10 Feb 2025	Rp87.2t	Rp70.6t	Rp3.1t	12.5x	27.7x	1.2x
Wed, 08 Jan 2025	Rp88.5t	Rp70.6t	Rp3.1t	12.7x	28.1x	1.3x
Fri, 06 Dec 2024	Rp99.5t	Rp70.6t	Rp3.1t	12.5x	31.6x	1.4x
Sun, 03 Nov 2024	Rp104.2t	Rp70.2t	Rp3.3t	12.3x	31.5x	1.5x
Tue, 01 Oct 2024	Rp112.0t	Rp68.8t	Rp3.3t	12.5x	33.9x	1.6x
Thu, 29 Aug 2024	Rp109.0t	Rp68.9t	Rp3.4t	12.8x	31.8x	1.6x
Sat, 27 Jul 2024	Rp99.1t	Rp67.5t	Rp3.0t	11.5x	33.4x	1.5x
Mon, 24 Jun 2024	Rp98.2t	Rp67.4t	Rp3.1t	15.4x	31.8x	1.5x
Wed, 22 May 2024	Rp95.7t	Rp67.7t	Rp4.4t	12.8x	21.7x	1.4x
Fri, 19 Apr 2024	Rp89.0t	Rp66.6t	Rp4.4t	14x	20.3x	1.3x
Sun, 17 Mar 2024	Rp89.9t	Rp65.9t	Rp4.7t	18.6x	19.1x	1.4x
Tue, 13 Feb 2024	Rp93.3t	Rp65.9t	Rp4.7t	18.7x	19.7x	1.4x
Thu, 11 Jan 2024	Rp99.8t	Rp65.9t	Rp4.7t	18.3x	21x	1.5x
Sat, 09 Dec 2023	Rp101.4t	Rp66.0t	Rp4.8t	19.6x	21.2x	1.5x
Mon, 06 Nov 2023	Rp97.5t	Rp65.9t	Rp5.5t	19.3x	17.7x	1.5x
Wed, 04 Oct 2023	Rp107.3t	Rp65.6t	Rp5.4t	21.8x	19.9x	1.6x
Fri, 01 Sep 2023	Rp109.6t	Rp65.6t	Rp5.4t	21.1x	20.3x	1.7x
Sun, 30 Jul 2023	Rp112.7t	Rp64.2t	Rp5.3t	21.2x	21.2x	1.8x
Tue, 27 Jun 2023	Rp119.1t	Rp64.2t	Rp5.3t	21x	22.4x	1.9x
Thu, 25 May 2023	Rp120.6t	Rp64.2t	Rp5.3t	21.2x	22.7x	1.9x
Sat, 22 Apr 2023	Rp120.8t	Rp64.2t	Rp4.8t	14.8x	25.2x	1.9x
Mon, 20 Mar 2023	Rp128.5t	Rp65.0t	Rp4.6t	20.3x	27.8x	2x

Price to Earnings Ratio

27.8x

Mon, 20 Mar 2023

Current Industry PE

Investors are pessimistic on the Indonesian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 20.1x which is lower than its 3-year average PE of 24.6x.

The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 1.2x.

Past Earnings Growth

The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
Meanwhile revenues for these companies have grown 4.7% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.